BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33091956)

  • 1. Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank.
    He MM; Fang Z; Hang D; Wang F; Polychronidis G; Wang L; Lo CH; Wang K; Zhong R; Knudsen MD; Smith SG; Xu RH; Song M
    Int J Cancer; 2021 Apr; 148(8):1867-1878. PubMed ID: 33091956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating liver function markers and the risk of COPD in the UK Biobank.
    Du W; Guan H; Wan X; Zhu Z; Yu H; Luo P; Chen L; Su J; Lu Y; Hang D; Tao R; Wu M; Zhou J; Fan X
    Front Endocrinol (Lausanne); 2023; 14():1121900. PubMed ID: 37033218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep and liver function biomarkers in relation to risk of incident liver cancer: a nationwide prospective cohort study.
    Song J; Fan L; Shi D; Lai X; Wang H; Liu W; Yu L; Liang R; Zhang Y; Wan S; Yang Y; Wang B
    BMC Med; 2024 Jun; 22(1):261. PubMed ID: 38915009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.
    Katzke V; Johnson T; Sookthai D; Hüsing A; Kühn T; Kaaks R
    BMJ Open; 2020 Mar; 10(3):e033532. PubMed ID: 32152162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study.
    Chen J; Dan L; Tu X; Sun Y; Deng M; Chen X; Hesketh T; Li R; Wang X; Li X
    Hepatol Int; 2023 Feb; 17(1):202-214. PubMed ID: 36194337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
    Kunutsor SK; Apekey TA; Khan H
    Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective association of liver function biomarkers with development of hepatobiliary cancers.
    Stepien M; Fedirko V; Duarte-Salles T; Ferrari P; Freisling H; Trepo E; Trichopoulou A; Bamia C; Weiderpass E; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Fagherazzi G; Racine A; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Lagiou P; Benetou V; Trichopoulos D; Palli D; Grioni S; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Peeters PH; Lund E; Quirós JR; Nápoles OC; Sánchez MJ; Dorronsoro M; Huerta JM; Ardanaz E; Ohlsson B; Sjöberg K; Werner M; Nystrom H; Khaw KT; Key TJ; Gunter M; Cross A; Riboli E; Romieu I; Jenab M
    Cancer Epidemiol; 2016 Feb; 40():179-87. PubMed ID: 26773278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
    Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
    JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
    Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
    Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tiopronin for the prevention of chemotherapy-related liver toxicity in advanced colorectal cancer patients treated with mFOLFOX7: a prospective analysis.
    Li XP; Wen F; Yang W; Deng YB; Li M; Zhang PF; Tang RL; Li Q; Wei YQ
    Tumori; 2014; 100(4):446-51. PubMed ID: 25296595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of serum liver enzyme levels and their changes over time with all-cause and cause-specific mortality in the general population: a large-scale national health screening cohort study.
    Kim KN; Joo J; Sung HK; Kim CH; Kim H; Kwon YJ
    BMJ Open; 2019 Jun; 9(5):e026965. PubMed ID: 31154308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver enzymes and incident diabetes in China: a prospective analysis of 10 764 participants in the Guangzhou Biobank Cohort Study.
    Xu L; Jiang CQ; Schooling CM; Zhang WS; Cheng KK; Lam TH
    J Epidemiol Community Health; 2015 Nov; 69(11):1040-4. PubMed ID: 26139641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.
    Liu X; Hamnvik OP; Chamberland JP; Petrou M; Gong H; Christophi CA; Christiani DC; Kales SN; Mantzoros CS
    Metabolism; 2014 Jun; 63(6):773-82. PubMed ID: 24726813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
    Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of liver function with plasma biomarkers for Alzheimer's Disease.
    Zhang B; Zhang C; Wang Y; Cheng L; Wang Y; Qiao Y; Peng D;
    Neurol Sci; 2024 Jun; 45(6):2625-2631. PubMed ID: 38177970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Γ-glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men.
    Wannamethee SG; Whincup PH; Shaper AG; Lennon L; Sattar N
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):830-5. PubMed ID: 22223732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of biochemical liver function tests in relation to age among steady state sickle cell anemia patients.
    Akuyam SA; Abubakar A; Lawal N; Yusuf R; Aminu SM; Hassan A; Musa A; Bello AK; Yahaya IA; Okafor PA
    Niger J Clin Pract; 2017 Nov; 20(11):1428-1433. PubMed ID: 29303127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Overweight and Obesity on Liver Biochemical Markers in Children and Adolescents.
    Johansen MJ; Gade J; Stender S; Frithioff-Bøjsøe C; Lund MAV; Chabanova E; Thomsen HS; Pedersen O; Fonvig CE; Hansen T; Holm JC
    J Clin Endocrinol Metab; 2020 Feb; 105(2):. PubMed ID: 31617910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
    Hann HW; Wan S; Myers RE; Hann RS; Xing J; Chen B; Yang H
    PLoS One; 2012; 7(10):e47687. PubMed ID: 23112834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
    Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF
    Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.